BioSpace News Archive

Axol, the rapidly growing specialist in human cell culture, is delighted to announce it has opened a new operational hub in the US.

Trauma center accreditation status has been granted to one additional hospital in Pennsylvania starting November 1, 2018.

Kala Pharmaceuticals, Inc. today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

Millions relying on botanicals to manage their well-being are threatened by 11th hour addition of new language in House Bill directed at Synthetic Opioids

Glaukos Corporation announced today that its products will be included in various physician presentations at the 36th Congress of the European Society of Cataract and Refractive Surgeons

uBiome Will Expand World’s Largest Human Microbiome Database and Advance Product Portfolio, Including Drug Discovery & Development

In celebration of Global Biotech Week, CDRD and BIOTECanada invite you to a thought-provoking evening to experience changes in life sciences and biotechnology that are unfolding today.

MabVax Therapeutics Holdings, Inc. (OTC: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs, announces today that the Court of Chancery of the State of Delaware (the “Court”) on September 20, 2018, granted the Company’s Verified Petition for Relief Under 8 Del.

MicuRx Pharmaceuticals Inc. today announced the receipt of the qualified infectious disease product (QIDP) classification and grant of fast track status by the U.S. Food and Drug Administration (FDA) for contezolid (MRX-I) and its prodrug contezolid acefosamil (MRX-4) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

Guided Therapeutics, Inc. today announced it has signed a letter of intent with its Russian and Eastern European Sales and Marketing partner, Newmars Group Kft., to accelerate marketing and sales of the LuViva Advanced Cervical Scan in those territories.